TRICHLORMETHIAZIDE: 342 Adverse Event Reports & Safety Profile
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
342
Total FAERS Reports
24 (7.0%)
Deaths Reported
240
Hospitalizations
342
As Primary/Secondary Suspect
24
Life-Threatening
9
Disabilities
Approved Prior to Jan 1, 1982
FDA Approved
Discontinued
Status
Yes
Generic Available
FDA Application: 012265 ·
First Report: 20010803 · Latest Report: 20250226
What Are the Most Common TRICHLORMETHIAZIDE Side Effects?
#1 Most Reported
Dyspnoea
105 reports (30.7%)
#2 Most Reported
Cough
104 reports (30.4%)
#3 Most Reported
Obstructive airways disorder
103 reports (30.1%)
All TRICHLORMETHIAZIDE Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Dyspnoea | 105 | 30.7% | 0 | 99 |
| Cough | 104 | 30.4% | 0 | 97 |
| Drug ineffective | 103 | 30.1% | 0 | 99 |
| Obstructive airways disorder | 103 | 30.1% | 0 | 97 |
| Pneumonia | 101 | 29.5% | 1 | 100 |
| Bronchial secretion retention | 97 | 28.4% | 0 | 97 |
| Eosinophil count increased | 97 | 28.4% | 0 | 97 |
| Multiple allergies | 97 | 28.4% | 0 | 97 |
| Pulmonary mass | 97 | 28.4% | 0 | 97 |
| Sputum culture positive | 97 | 28.4% | 0 | 97 |
| Upper-airway cough syndrome | 97 | 28.4% | 0 | 97 |
| Respiratory tract infection | 96 | 28.1% | 0 | 96 |
| Vital capacity decreased | 96 | 28.1% | 0 | 96 |
| Reversible airways obstruction | 95 | 27.8% | 0 | 95 |
| Full blood count abnormal | 79 | 23.1% | 0 | 75 |
| Hyponatraemia | 28 | 8.2% | 3 | 21 |
| Blood count abnormal | 24 | 7.0% | 0 | 22 |
| Sputum culture | 21 | 6.1% | 0 | 21 |
| Acute kidney injury | 20 | 5.9% | 1 | 16 |
| Dehydration | 20 | 5.9% | 3 | 17 |
Who Reports TRICHLORMETHIAZIDE Side Effects? Age & Gender Data
Gender: 66.0% female, 34.0% male. Average age: 75.9 years. Most reports from: JP. View detailed demographics →
Is TRICHLORMETHIAZIDE Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2001 | 2 | 0 | 2 |
| 2009 | 1 | 1 | 0 |
| 2010 | 2 | 0 | 0 |
| 2011 | 2 | 1 | 2 |
| 2012 | 8 | 0 | 6 |
| 2013 | 9 | 1 | 8 |
| 2014 | 7 | 2 | 6 |
| 2015 | 8 | 1 | 2 |
| 2016 | 18 | 3 | 13 |
| 2017 | 25 | 5 | 18 |
| 2018 | 16 | 2 | 10 |
| 2019 | 10 | 1 | 8 |
| 2020 | 4 | 1 | 3 |
| 2021 | 5 | 0 | 4 |
| 2022 | 10 | 3 | 4 |
| 2023 | 3 | 1 | 2 |
| 2024 | 4 | 0 | 3 |
| 2025 | 1 | 0 | 1 |
What Is TRICHLORMETHIAZIDE Used For?
| Indication | Reports |
|---|---|
| Product used for unknown indication | 174 |
| Hypertension | 65 |
| Cardiac failure | 14 |
| Blood pressure abnormal | 9 |
| Cardiac failure congestive | 9 |
| Cardiac failure chronic | 5 |
TRICHLORMETHIAZIDE vs Alternatives: Which Is Safer?
TRICHLORMETHIAZIDE vs TRICLOSAN
TRICHLORMETHIAZIDE vs TRIENTINE
TRICHLORMETHIAZIDE vs TRIENTINE TETRAHYDROCHLORIDE
TRICHLORMETHIAZIDE vs TRIFAROTENE
TRICHLORMETHIAZIDE vs TRIFLUOPERAZINE
TRICHLORMETHIAZIDE vs TRIFLURIDINE
TRICHLORMETHIAZIDE vs TRIHEPTANOIN
TRICHLORMETHIAZIDE vs TRIHEXYPHENIDYL
TRICHLORMETHIAZIDE vs TRILACICLIB
TRICHLORMETHIAZIDE vs TRILEPTAL
Official FDA Label for TRICHLORMETHIAZIDE
Official prescribing information from the FDA-approved drug label.